Bimodal Contrast Agent Advances Medical Imaging
By MedImaging International staff writers Posted on 19 Aug 2019 |
A new study details a two-in-one probe made of a contrast agent for magnetic resonance imaging (MRI) and a dye for photoacoustic imaging (PI).
Developed at the University of Mons (Belgium) and the Center of Microscopy and Molecular Imaging (CMMI; Charleroi, Belgium), the bimodal agent combines the MRI gadolinium agent Gd-PCTA, and an organic fluorophore dye called ZW800-1. A L‐lysine derivative joins the two via conventional protein end connections. The L‐lysine derivative also possesses a third connectivity, which can be of used to add another biovector, such as a peptide that specifically recognizes a biological disorder. This could make the bimodal probe trimodal.
The bimodal probe enhances MRI contrast as strongly as a commercial MRI agent, while at the same time providing a photoacoustic signal similar to the original PAI probe. The probe can thus provide hybrid images with a high anatomical resolution provided by MRI, and precise localization of the contrast agent thanks to PAI. Preliminary relaxometric and photoacoustic characterizations indicate that the bimodal agent fulfills its function. The study was published on June 26, 2019, in the European Journal of Inorganic Chemistry.
“The aim is to improve the image by combining photoacoustic imaging and magnetic resonance imaging by using a bimodal probe,” said Professor Sophie Laurent, PhD, of the University of Mons. “The organic dye enables PAI, thanks to its fluorescence in the near infrared (NIRF), and the gadolinium complex based on PCTA is ideal for MRI with radio-frequency pulses. The combination leads to a precisely localized, high-resolution bimodal image.”
Related Links:
University of Mons
Center of Microscopy and Molecular Imaging
Developed at the University of Mons (Belgium) and the Center of Microscopy and Molecular Imaging (CMMI; Charleroi, Belgium), the bimodal agent combines the MRI gadolinium agent Gd-PCTA, and an organic fluorophore dye called ZW800-1. A L‐lysine derivative joins the two via conventional protein end connections. The L‐lysine derivative also possesses a third connectivity, which can be of used to add another biovector, such as a peptide that specifically recognizes a biological disorder. This could make the bimodal probe trimodal.
The bimodal probe enhances MRI contrast as strongly as a commercial MRI agent, while at the same time providing a photoacoustic signal similar to the original PAI probe. The probe can thus provide hybrid images with a high anatomical resolution provided by MRI, and precise localization of the contrast agent thanks to PAI. Preliminary relaxometric and photoacoustic characterizations indicate that the bimodal agent fulfills its function. The study was published on June 26, 2019, in the European Journal of Inorganic Chemistry.
“The aim is to improve the image by combining photoacoustic imaging and magnetic resonance imaging by using a bimodal probe,” said Professor Sophie Laurent, PhD, of the University of Mons. “The organic dye enables PAI, thanks to its fluorescence in the near infrared (NIRF), and the gadolinium complex based on PCTA is ideal for MRI with radio-frequency pulses. The combination leads to a precisely localized, high-resolution bimodal image.”
Related Links:
University of Mons
Center of Microscopy and Molecular Imaging
Latest General/Advanced Imaging News
- Radiation Therapy Computed Tomography Solution Boosts Imaging Accuracy
- PET Scans Reveal Hidden Inflammation in Multiple Sclerosis Patients
- Artificial Intelligence Evaluates Cardiovascular Risk from CT Scans
- New AI Method Captures Uncertainty in Medical Images
- CT Coronary Angiography Reduces Need for Invasive Tests to Diagnose Coronary Artery Disease
- Novel Blood Test Could Reduce Need for PET Imaging of Patients with Alzheimer’s
- CT-Based Deep Learning Algorithm Accurately Differentiates Benign From Malignant Vertebral Fractures
- Minimally Invasive Procedure Could Help Patients Avoid Thyroid Surgery
- Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery
- AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning
- Imaging Technology Provides Ground-Breaking New Approach for Diagnosing and Treating Bowel Cancer
- CT Coronary Calcium Scoring Predicts Heart Attacks and Strokes
- AI Model Detects 90% of Lymphatic Cancer Cases from PET and CT Images
- Breakthrough Technology Revolutionizes Breast Imaging
- State-Of-The-Art System Enhances Accuracy of Image-Guided Diagnostic and Interventional Procedures
- Catheter-Based Device with New Cardiovascular Imaging Approach Offers Unprecedented View of Dangerous Plaques